Healio1d
Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes
Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...
pharmaphorum1d
Patients resist Novo Nordisk plan to stop making Levemir
and biosimilars and Novo Nordisk's newer product Tresiba (insulin degludec), but is more suitable for people with fluctuating basal insulin needs, claims the group. That shorter half-life makes it ...
pharmaphorum2d
Novo Nordisk once-weekly insulin clears first phase 3 test
The results of the ONWARDS 2 trial of insulin icodec showed that it was as effective as daily dosing with Novo Nordisk's Tresiba (insulin degludec) once per day at controlling blood glucose, as ...
Study suggests inhaled technosphere insulin could be considered as an option for adults with type 1 diabetes
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
Automated insulin delivery improves glycemic control of type 2 diabetes in randomized trial
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
EurekAlert!3d
Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 diabetes
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...